FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039301503> ?p ?o ?g. }

• W2039301503 endingPage "161" @default.
• W2039301503 startingPage "157" @default.
• W2039301503 abstract "The inhibitory effects of five calcium channel blockers (diltiazem, isradipine, mibefradil, nifedipine and verapamil) and three azole antifungal agents (itraconazole, hydroxyitraconazole and ketoconazole) on the alpha-hydroxylation of midazolam, a probe drug for CYP3A4-mediated interactions in humans, were studied in vitro using human liver microsomes. IC50 and Ki values were determined for each inhibitor. The kinetics of the formation of alpha-hydroxymidazolam were best described by simple Michaelis-Menten kinetics. The estimated values of Vmax and Km were 696 pmol min.-(1) mg(-1) and 7.46 micromol l(-1), respectively. All the compounds studied inhibited midazolam alpha-hydroxylation activity in a concentration-dependent manner, but there were marked differences in their relative inhibitory potency. Ketoconazole was the most potent inhibitor of midazolam alpha-hydroxylation (IC50 0.12 micromol l (-1)), being 10 times more potent than itraconazole (IC50 1.2 micromol l(-1)). The inhibitory effect of hydroxyitraconazole (IC50 2.3 micromol l (-1) was almost as large as that of itraconazole. Among the calcium channel blockers, mibefradil was the most potent inhibitor of the alpha-hydroxylation of midazolam, with an IC50 value (1.6 micromol l (-1)) similar to that of itraconazole. The other calcium channel blockers were much weaker inhibitors than mibefradil: verapamil exhibited a modest inhibitory effect with an IC50 of 23 micromol l(-1), while isradipine, nifedipine and diltiazem, with IC50 values ranging from 57 to >100 micromol l (-1), were weak inhibitors. This rank order of potency against the alpha-hydroxylation Qf midazolam was verified by the Ki values. With the exception of diltiazem, these in vitro results conform with the observed interaction potential of these agents with midazolam and many other CYP3A4 substrates in vivo in man." @default.
• W2039301503 created "2016-06-24" @default.
• W2039301503 creator A5005608801 @default.
• W2039301503 creator A5050719752 @default.
• W2039301503 creator A5054445393 @default.
• W2039301503 creator A5056451757 @default.
• W2039301503 creator A5075309527 @default.
• W2039301503 creator A5089475081 @default.
• W2039301503 date "1999-12-01" @default.
• W2039301503 modified "2023-10-18" @default.
• W2039301503 title "Midazolam α-Hydroxylation by Human Liver Microsomes<i>in vitro</i>: Inhibition by Calcium Channel Blockers, Itraconazole and Ketoconazole" @default.
• W2039301503 cites W161985329 @default.
• W2039301503 cites W1963854375 @default.
• W2039301503 cites W1972764254 @default.
• W2039301503 cites W1985419749 @default.
• W2039301503 cites W1985984753 @default.
• W2039301503 cites W1991684478 @default.
• W2039301503 cites W1993536574 @default.
• W2039301503 cites W1996485240 @default.
• W2039301503 cites W2004576165 @default.
• W2039301503 cites W2010870873 @default.
• W2039301503 cites W2012293219 @default.
• W2039301503 cites W2013373097 @default.
• W2039301503 cites W2040869398 @default.
• W2039301503 cites W2050450820 @default.
• W2039301503 cites W2050936227 @default.
• W2039301503 cites W2051654560 @default.
• W2039301503 cites W2054040800 @default.
• W2039301503 cites W2056863521 @default.
• W2039301503 cites W2068475987 @default.
• W2039301503 cites W2077199559 @default.
• W2039301503 cites W2082314577 @default.
• W2039301503 cites W2092869459 @default.
• W2039301503 cites W2127288395 @default.
• W2039301503 cites W2145879423 @default.
• W2039301503 cites W2162946847 @default.
• W2039301503 cites W4254910660 @default.
• W2039301503 doi "https://doi.org/10.1111/j.1600-0773.1999.tb00085.x" @default.
• W2039301503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10563513" @default.
• W2039301503 hasPublicationYear "1999" @default.
• W2039301503 type Work @default.
• W2039301503 sameAs 2039301503 @default.
• W2039301503 citedByCount "64" @default.
• W2039301503 countsByYear W20393015032012 @default.
• W2039301503 countsByYear W20393015032013 @default.
• W2039301503 countsByYear W20393015032014 @default.
• W2039301503 countsByYear W20393015032015 @default.
• W2039301503 countsByYear W20393015032016 @default.
• W2039301503 countsByYear W20393015032017 @default.
• W2039301503 countsByYear W20393015032018 @default.
• W2039301503 countsByYear W20393015032019 @default.
• W2039301503 countsByYear W20393015032020 @default.
• W2039301503 countsByYear W20393015032021 @default.
• W2039301503 countsByYear W20393015032022 @default.
• W2039301503 crossrefType "journal-article" @default.
• W2039301503 hasAuthorship W2039301503A5005608801 @default.
• W2039301503 hasAuthorship W2039301503A5050719752 @default.
• W2039301503 hasAuthorship W2039301503A5054445393 @default.
• W2039301503 hasAuthorship W2039301503A5056451757 @default.
• W2039301503 hasAuthorship W2039301503A5075309527 @default.
• W2039301503 hasAuthorship W2039301503A5089475081 @default.
• W2039301503 hasBestOaLocation W20393015031 @default.
• W2039301503 hasConcept C109650736 @default.
• W2039301503 hasConcept C178790620 @default.
• W2039301503 hasConcept C181199279 @default.
• W2039301503 hasConcept C185592680 @default.
• W2039301503 hasConcept C202751555 @default.
• W2039301503 hasConcept C2776741139 @default.
• W2039301503 hasConcept C2777022698 @default.
• W2039301503 hasConcept C2777071850 @default.
• W2039301503 hasConcept C2777752497 @default.
• W2039301503 hasConcept C2778673320 @default.
• W2039301503 hasConcept C2779066535 @default.
• W2039301503 hasConcept C2779548794 @default.
• W2039301503 hasConcept C2781064554 @default.
• W2039301503 hasConcept C2781109383 @default.
• W2039301503 hasConcept C519063684 @default.
• W2039301503 hasConcept C526171541 @default.
• W2039301503 hasConcept C55493867 @default.
• W2039301503 hasConcept C62231903 @default.
• W2039301503 hasConcept C85520022 @default.
• W2039301503 hasConcept C86803240 @default.
• W2039301503 hasConcept C87644729 @default.
• W2039301503 hasConcept C89423630 @default.
• W2039301503 hasConcept C98274493 @default.
• W2039301503 hasConceptScore W2039301503C109650736 @default.
• W2039301503 hasConceptScore W2039301503C178790620 @default.
• W2039301503 hasConceptScore W2039301503C181199279 @default.
• W2039301503 hasConceptScore W2039301503C185592680 @default.
• W2039301503 hasConceptScore W2039301503C202751555 @default.
• W2039301503 hasConceptScore W2039301503C2776741139 @default.
• W2039301503 hasConceptScore W2039301503C2777022698 @default.
• W2039301503 hasConceptScore W2039301503C2777071850 @default.
• W2039301503 hasConceptScore W2039301503C2777752497 @default.
• W2039301503 hasConceptScore W2039301503C2778673320 @default.
• W2039301503 hasConceptScore W2039301503C2779066535 @default.
• W2039301503 hasConceptScore W2039301503C2779548794 @default.
• W2039301503 hasConceptScore W2039301503C2781064554 @default.

• next